KRM Ayurveda Limited has announced a significant financial milestone, crossing the JPY 100 crore revenue mark in the second half of fiscal year 2026. The company reported a 100% year-on-year growth in EBITDA for H2 FY26, while profit after tax (PAT) surged by 149%, with PAT margins nearly doubling during the period.
Strong Operational Performance
The robust financial performance underscores the company's operational efficiency and market expansion strategies. KRM Ayurveda's focus on high-quality Ayurvedic products and increased consumer demand has driven revenue growth across domestic and international markets.
Key Financial Highlights
- Revenue: Crossed JPY 100 crore in H2 FY26, reflecting strong sales momentum.
- EBITDA: Grew 100% year-on-year, driven by cost optimization and higher volumes.
- PAT: Surged 149% compared to the same period last year, with PAT margins nearly doubling.
- Margin Expansion: Improved profitability due to better product mix and operational leverage.
Strategic Initiatives Driving Growth
The company has invested in expanding its product portfolio, strengthening distribution networks, and enhancing brand visibility. KRM Ayurveda's commitment to research and development has led to innovative formulations that cater to evolving consumer preferences for natural and holistic wellness solutions.
Future Outlook
Management remains optimistic about sustaining growth momentum, with plans to further penetrate international markets and introduce new product lines. The company aims to leverage its strong financial position to invest in capacity expansion and digital transformation initiatives.
This milestone positions KRM Ayurveda as a key player in the Ayurvedic industry, with a focus on delivering value to shareholders and promoting traditional wellness practices globally.
